Late Breaking Abstract - Efficacy and safety of benralizumab in patients with severe uncontrolled asthma despite ICS-LABA: a randomised, double-blind, placebo-controlled phase 3 trial in Asia (MIRACLE)

被引：0

作者：

Lai, Kefang ^{[1
]}

Sun, Dejun ^{[2
]}

Dai, Ranran ^{[3
]}

Samoro, Ronnie ^{[4
]}

Park, Hae-Sim ^{[5
]}

Astrand, Annika ^{[6
]}

Cohen, David ^{[7
]}

Jison, Maria ^{[7
]}

Shih, Vivian ^{[8
]}

Werkstrom, Viktoria ^{[6
]}

Yao, Yuhui ^{[9
]}

Zhang, Yajuan ^{[9
]}

Zheng, Wenying ^{[10
]}

Zhong, Nanshan ^{[1
]}

机构：

[1] Guangzhou Med Univ, State Key Lab Resp Dis, Natl Clin Res Ctr Resp Dis, Guangzhou Inst Resp Hlth,Affiliated Hosp 1, Guangzhou, Peoples R China

[2] Inner Mongolia Peoples Hosp, Hohhot, Peoples R China

[3] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Shanghai, Peoples R China

[4] Healthlink Med Surg Dent Clin & Diagnost Ctr, Iloilo, Philippines

[5] Ajou Univ Hosp, Suwon, South Korea

[6] AstraZeneca, Late Stage Resp & Immunol, Gothenburg, Sweden

[7] AstraZeneca, Late Stage Resp & Immunol, Gaithersburg, MD USA

[8] AstraZeneca, BioPharmaceut Med, Gaithersburg, MD USA

[9] AstraZeneca, Resp & Immunol, R&D China, Shanghai, Peoples R China

[10] AstraZeneca, R&D China, Biometr, Shanghai, Peoples R China

来源：

EUROPEAN RESPIRATORY JOURNAL | 2023年 / 62卷

关键词：

D O I：

10.1183/13993003.congress-2023.PA4130

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

引用

页数：3

共 50 条

[11] Safety and efficacy of pitolisant on cataplexy in patients with narcolepsy: a randomised, double-blind, placebo-controlled trial
Szakacs, Zoltan
Dauvilliers, Yves
Mikhaylov, Vladimir
Poverennova, Irina
Krylov, Sergei
Jankovic, Slavko
Sonka, Karel
Lehert, Philippe
Lecomte, Isabelle
Lecomte, Jeanne-Marie
Schwartz, Jean-Charles
LANCET NEUROLOGY, 2017, 16 (03): : 200 - 207
[12] Efficacy and safety of a CXCR2 antagonist, AZD5069, in patients with uncontrolled persistent asthma: a randomised, double-blind, placebo-controlled trial
O'Byrne, Paul M.
Metev, Hristo
Puu, Margareta
Richter, Kai
Keen, Christina
Uddin, Mohib
Larsson, Bengt
Cullberg, Marie
Nair, Parameswaran
LANCET RESPIRATORY MEDICINE, 2016, 4 (10): : 797 - 806
[13] Late Breaking Abstract - A randomised, double-blind, placebo controlled, clinical trial evaluating imatinib in patients with severe COVID-19
Aman, Jurjan
Duijvelaar, Erik
Botros, Liza
Kianzad, Azar
Schippers, Job
Smeele, Patrick
Azhang, Sara
Bartelink, Imke
Bet, Pierre
Boersma, Wim
Boomars, Karin
Bonta, Peter
Bos, Lieuwe
Van Bragt, Job
Braunstahl, Gert-Jan
Celant, Lucas
Eger, Katrien
Geelhoed, Miranda
Van Glabbeek, Yurika
Grotjohan, Hans
Hagens, Laura
Happe, Chris
Heunks, Leo
Van Den Heuvel, Michel
Hoefsloot, Wouter
Hoek, Rianne
Hoekstra, Romke
Hofstee, Herman
Vanhove, Arthur
Juffermans, Nicole
Lammers, Marije
Kos, Renate
Kemper, Marleen
Kunst, Peter
Van Der Lee, Ivo
Van Der Lee, Laurien
Mau-Asam, Pearl
Maitland-Van Der Zee, Anke-Hilse
Mieras, Adinda
Nossent, Esther
Overbeek, Marieke
Oswald, Laurien
Paternotte, Nienke
Pamplona, Carol
Pronk, Niels
De Raaf, Michiel
Slob, Elise
Neto, Ary Serpa
Schultz, Marcus
Smit, Marry
EUROPEAN RESPIRATORY JOURNAL, 2021, 58
[14] Efficacy and safety of volanesorsen in patients with multifactorial chylomicronaemia (COMPASS): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
Gouni-Berthold, Ioanna
Alexander, Veronica J.
Yang, Qingqing
Hurh, Eunju
Steinhagen-Thiessen, Elisabeth
Moriarty, Patrick M.
Hughes, Stephen G.
Gaudet, Daniel
Hegele, Robert A.
O'Dea, Louis St L.
Stroes, Erik S. G.
Tsimikas, Sotirios
Witztum, Joseph L.
LANCET DIABETES & ENDOCRINOLOGY, 2021, 9 (05): : 264 - 275
[15] Efficacy and Safety of Tofacitinib in Ankylosing Spondylitis: A Randomised, Double-blind, Placebo-controlled Trial
Harish, B., V
Sahoo, Rasmi Ranjan
Gochhait, Samanyoya
Patro, Pradeepta Sekhar
INDIAN JOURNAL OF RHEUMATOLOGY, 2025, 20 (01) : 27 - 34
[16] A randomised, double-blind, placebo-controlled phase III trial on the efficacy and safety of tocilizumab in patients with familial Mediterranean fever
Koga, T.
Sato, S.
Hagimori, N.
Yamamoto, H.
Ishimura, M.
Yasumi, T.
Kirino, Y.
Ikeda, K.
Yachie, A.
Migita, K.
Kishida, D.
Atsumi, T.
Kawakami, A.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2022, 40 (08) : 1535 - 1542
[17] Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial
Meininger, Vincent
Genge, Angela
van den Berg, Leonard H.
Robberecht, Wim
Ludolph, Albert
Chio, Adriano
Kim, Seung H.
Leigh, P. Nigel
Kiernan, Matthew C.
Shefner, Jeremy M.
Desnuelle, Claude
Morrison, Karen E.
Petri, Susanne
Boswell, Diane
Temple, Jane
Mohindra, Rajat
Davies, Matt
Bullman, Jonathan
Rees, Paul
Lavrov, Arseniy
LANCET NEUROLOGY, 2017, 16 (03): : 208 - 216
[18] Cyclosporin for moderate to severe alopecia areata: A double-blind, randomised, placebo-controlled clinical trial of efficacy and safety
Lai, V.
Chen, G.
Gin, D.
Sinclair, R.
AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2019, 60 : 56 - 56
[19] Safety and efficacy of thalidomide in patients with POEMS syndrome: a multicentre, randomised, double-blind, placebo-controlled trial
Misawa, Sonoko
Sato, Yasunori
Katayama, Kanako
Nagashima, Kengo
Aoyagi, Reiko
Sekiguchi, Yukari
Sobue, Gen
Koike, Haruki
Yabe, Ichiro
Sasaki, Hidenao
Watanabe, Osamu
Takashima, Hiroshi
Nishizawa, Masatoyo
Kawachi, Izumi
Kusunoki, Susumu
Mitsui, Yoshiyuki
Kikuchi, Seiji
Nakashima, Ichiro
Ikeda, Shu-ichi
Kohara, Nobuo
Kanda, Takashi
Kira, Jun-ichi
Hanaoka, Hideki
Kuwabara, Satoshi
LANCET NEUROLOGY, 2016, 15 (11): : 1129 - 1137
[20] Bimekizumab efficacy and safety in moderate to severe plaque psoriasis (BE READY): a multicentre, double-blind, placebo-controlled, randomised withdrawal phase 3 trial
Gordon, Kenneth B.
Foley, Peter
Krueger, James G.
Pinter, Andreas
Reich, Kristian
Vender, Ronald
Vanvoorden, Veerle
Madden, Cynthia
White, Katy
Cioffi, Christopher
Blauvelt, Andrew
LANCET, 2021, 397 (10273): : 475 - 486

← 1 2 3 4 5 →